1
|
Zhang C, Dong J, Shen T, Li Y, Yang Z, Cheng X, Luo H, Yang J, Shi Z, Wang W, Zhang X. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 2018; 21:1414-1420. [PMID: 30588595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
OBJECTIVE To compare the application among intensity-modulated radiotherapy (IMRT), three-dimensional conformal radiotherapy(3D-CRT) and conventional radiotherapy (CRT) for locally advanced middle-low rectal cancer. METHODS From January 2015 to December 2016, 93 locally advanced middle-low rectal cancer patients with clinical stage cT3N+M0 or cT4N0/+M0 who underwent preoperative concurrent chemoradiotherapy at Department of Colorectal Surgery, the Third Affiliated Hospital of Kunming Medical University and had complete data were enrolled in this retrospective cohort study. Patients were divided into IMRT group (17 cases), 3D-CRT group (28 cases) and CRT group (48 cases) according to different radiotherapy methods. The frequency and dose of CRT were 1 time/day, 5 times/week, for a total of 5 weeks, with a single dose of 2.0 Gy, the total dose was 50 Gy. Frequency and dose of 3D-CRT and IMRT were 1 time/day, 5 times/week, for a total of 23 to 28 times, with a single dose of 1.8 to 2.0 Gy, and a total dose of 45.0 to 50.4 Gy. The chemotherapy regimen was performed with capecitabine tablets at a dose of 825 mg/m2 twice a day for 5 days every week, at the same time during radiotherapy. The efficacy, chemotherapy adverse reactions and immune function of the three groups were compared. RESULTS There was no significant difference in the baseline data among the three groups (all P>0.05). The proportion of patients receiving permanent ostomy in the IMRT group and the 3D-CRT group was 29.4%(5/17) and 32.1%(9/28) respectively, which was lower than 58.3%(28/48) in CRT group, and the difference was statistically significant (χ²=7.982, P=0.030), while this proportion was not significantly different between IMRT and 3D-CRT group(χ²=0.037, P=0.848). The pathologic complete response(pCR) rate was 23.7%(22/93) in the whole study, and the pCR rate was 39.3%(11/28) in the 3D-CRT group, which was higher than that of CRT group and IMRT group [12.5%(6/48) and 29.4%(5/17)], and the difference was statistically significant (χ²=7.407, P=0.025), while there was no significant difference in pCR rate between CRT group and IMRT group (χ²=2.554, P=0.110). There was no adverse reaction of grade 3 or above in all three groups. No significant difference in the incidence of bone marrow suppression, abnormal liver and kidney function markers, digestive tract reaction or radiation dermatitis was found(all P>0.05). After receiving concurrent chemoradiotherapy, the proportion of CD3/CD4 cells in the IMRT group and the CRT group decreased compared with that before treatment(23.1±9.3 vs. 31.1±10.9, 27.4±10.7 vs. 33.6±7.2, respectively); the proportion of CD3/CD8 cells was up-regulated (36.1±15.2 vs. 24.8±10.9, 30.9±14.4 vs. 24.0±8.3,respectively), and the differences were statistically significant (both P<0.05), while the above indexes before and after treatment were not significantly different in the 3D-CRT group(all P>0.05). After treatment, the proportion of CD4/CD8 cells in IMRT group decreased (0.8±0.6 vs. 1.6±1.0, t=3.838, P=0.003), while this proportion was not significantly different in CRT group and 3D-CRT group(all P>0.05). CONCLUSIONS IMRT and 3D-CRT can reduce the rate of permanent stoma. 3D-CRT can increase pCR rate. No obvious advantage is shown in IMRT as compared with 3D-CRT in the short-term efficacy. On the contrary, an immunosuppressive status may occur. Therefore, 3D-CRT is recommended as the best preoperative treatment strategy for patients with locally advanced middle-low rectal cancer, especially for those with immunosuppression status.
Collapse
Affiliation(s)
- Ce Zhang
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Jianhua Dong
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Tao Shen
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Yunfeng Li
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Zhibin Yang
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Xianshuo Cheng
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Hui Luo
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Jiali Yang
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Zhiyu Shi
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| | - Weiya Wang
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China,
| | - Xuan Zhang
- Department of Colorectal Surgery, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital, Kunming Medical University, Kunming 650118, China
| |
Collapse
|
2
|
De Ruysscher D, Faivre-Finn C, Moeller D, Nestle U, Hurkmans CW, Le Péchoux C, Belderbos J, Guckenberger M, Senan S. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol 2017; 124:1-10. [PMID: 28666551 DOI: 10.1016/j.radonc.2017.06.003] [Citation(s) in RCA: 133] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2017] [Revised: 04/25/2017] [Accepted: 06/05/2017] [Indexed: 12/23/2022]
Abstract
PURPOSE To update literature-based recommendations for techniques used in high-precision thoracic radiotherapy for lung cancer, in both routine practice and clinical trials. METHODS A literature search was performed to identify published articles that were considered clinically relevant and practical to use. Recommendations were categorised under the following headings: patient positioning and immobilisation, Tumour and nodal changes, CT and FDG-PET imaging, target volumes definition, radiotherapy treatment planning and treatment delivery. An adapted grading of evidence from the Infectious Disease Society of America, and for models the TRIPOD criteria, were used. RESULTS Recommendations were identified for each of the above categories. CONCLUSION Recommendations for the clinical implementation of high-precision conformal radiotherapy and stereotactic body radiotherapy for lung tumours were identified from the literature. Techniques that were considered investigational at present are highlighted.
Collapse
Affiliation(s)
- Dirk De Ruysscher
- Maastricht University Medical Center+, Department of Radiation Oncology (Maastro Clinic), GROW Research Institute, The Netherlands; KU Leuven, Radiation Oncology, Belgium.
| | - Corinne Faivre-Finn
- Division of Cancer Sciences University of Manchester, Christie NHS Foundation Trust, UK
| | - Ditte Moeller
- Aarhus University Hospital, Department of Oncology, Denmark
| | - Ursula Nestle
- Freiburg University Medical Center (DKTK partner site), Department of Radiation Oncology, Germany; Department of Radiation Oncology, Kliniken Maria Hilf, Moenchengladbach, Germany
| | - Coen W Hurkmans
- Catharina Hospital, Department of Radiation Oncology, Eindhoven, The Netherlands
| | | | - José Belderbos
- Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands
| | | | - Suresh Senan
- VU University Medical Center, Department of Radiation Oncology, Amsterdam, The Netherlands
| |
Collapse
|
3
|
Fitzgerald R, Owen R, Barry T, Hargrave C, Pryor D, Bernard A, Lehman M, Mai T, Fielding A. The effect of beam arrangements and the impact of non-coplanar beams on the treatment planning of stereotactic ablative radiation therapy for early stage lung cancer. J Med Radiat Sci 2016; 63:31-40. [PMID: 27087973 PMCID: PMC4775835 DOI: 10.1002/jmrs.118] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2015] [Revised: 03/30/2015] [Accepted: 06/10/2015] [Indexed: 12/25/2022] Open
Abstract
INTRODUCTION The aim of this study was to compare various coplanar and non-coplanar 3-dimensional conformal radiation therapy (3DCRT) beam arrangements for the delivery of stereotactic ablative radiation therapy (SABR) to patients with early stage lung cancer, based on the dosimetric criteria from the Radiation Therapy Oncology Group (RTOG) 1021 protocol. METHODS Ten medically inoperable lung cancer patients eligible for SABR were re-planned using three different coplanar and three different non-coplanar beam arrangements. The plans were compared by assessing planning target volume (PTV) coverage, doses to normal tissues, the high-dose conformity (conformity index) and intermediate dose spillage as defined by the D2cm, (the dose at any point 2 cm away from the PTV), and the R50% (the ratio of the volume of half the prescription dose to the volume of the PTV). RESULTS Sixty plans in total were assessed. Mean PTV coverage with the prescription isodose was similar between coplanar (95.14%) and non-coplanar (95.26%) techniques (P = 0.47). There was significant difference between all coplanar and all non-coplanar fields for the R50% (P < 0.0001) but none for the D2cm (P = 0.19). The seven and nine field beam arrangements with two non-coplanar fields had less unacceptable protocol deviations (10 and 7) than the seven and nine field plans with only coplanar fields (13 and 8). The 13 field coplanar fields did not improve protocol compliance with eight unacceptable deviations. The 10 field non-coplanar beam arrangement achieved best compliance with the RTOG 1021 dose criteria with only one unacceptable deviation (maximum rib dose). CONCLUSION A 3DCRT planning technique using 10 fields with ≥6 non-coplanar beams best satisfied high and intermediate dose constraints stipulated in the RTOG 1021 trial. Further investigations are required to determine if minor protocol deviations should be balanced against efficiency with the extended treatment times required to deliver non-coplanar fields and if treatment times can be improved using novel intensity modulated techniques.
Collapse
Affiliation(s)
- Rhys Fitzgerald
- Division of Radiation TherapyPrincess Alexandra HospitalWoolloongabbaQueenslandAustralia
- Science and Engineering FacultyQueensland University of TechnologyBrisbaneQueenslandAustralia
| | - Rebecca Owen
- Radiation Oncology Mater CentreSouth BrisbaneQueenslandAustralia
| | - Tamara Barry
- Division of Radiation TherapyPrincess Alexandra HospitalWoolloongabbaQueenslandAustralia
| | - Cathy Hargrave
- Radiation Oncology Mater CentreSouth BrisbaneQueenslandAustralia
| | - David Pryor
- Department of Radiation OncologyPrincess Alexandra HospitalWoolloongabbaQueenslandAustralia
| | - Anne Bernard
- QFAB BioinformaticsThe University of QueenslandQueensland Bioscience PrecinctSt LuciaQueenslandAustralia
| | - Margot Lehman
- Department of Radiation OncologyPrincess Alexandra HospitalWoolloongabbaQueenslandAustralia
| | - Tao Mai
- Department of Radiation OncologyPrincess Alexandra HospitalWoolloongabbaQueenslandAustralia
| | - Andrew Fielding
- Science and Engineering FacultyQueensland University of TechnologyBrisbaneQueenslandAustralia
| |
Collapse
|
4
|
Grimm M, Wenz F. [Localized prostate cancer: Radiotherapeutic concepts]. Urologe A 2016; 55:326-32. [PMID: 26895435 DOI: 10.1007/s00120-016-0042-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
BACKGROUND Radiation therapy is an established cornerstone in the treatment of prostate cancer. Significant advances in the techniques and therapeutic concepts have been made in recent decades. OBJECTIVES The objective of this article is to provide an overview of current standards of care and recent technical and conceptional developments. CONCLUSIONS Three-dimensional conformal radiotherapy has long been the standard of care for percutaneous radiotherapy. The development of intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) have increased the precision of treatment, thus, reducing side effects and allowing dose escalation. LDR (low dose rate) and HDR (high dose rate) brachytherapy alone or in combination are a treatment option in localized prostate cancer with a distinct side effect profile. The roles of proton therapy and stereotactic radiotherapy should be further investigated in prospective trials.
Collapse
Affiliation(s)
- M Grimm
- Klinik für Strahlentherapie und Radioonkologie, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Deutschland.
| | - F Wenz
- Klinik für Strahlentherapie und Radioonkologie, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Deutschland
| |
Collapse
|
5
|
Diamantopoulos S, Thalassinou S, Efstathopoulos E, Dilvoi M, Patatoukas G, Kouloulias V, Platoni K. In vivo dosimetry in the field junction area for 3D-conformal radiation therapy in breast and head & neck cancer cases: A quality assurance study. J BUON 2016; 21:1104-1112. [PMID: 27837611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
PURPOSE To investigate the accuracy of field junctioning planning techniques (monoisocentric and rotating couch technique) for 3D-conformal radiotherapy (3D-CRT). METHODS In vivo dosimetry has been performed using thermo- luminescence dosimeters (TLDs) in 10 head and neck cancer patients (treated with monoisocentric technique) and 10 breast cancer patients (treated with rotating couch technique) irradiated with a 6 MV photon beam. Entrance dose measurements were performed in selected regions including the field junction area. RESULTS The mean deviation between measured and expected dose in the region of junction was significantly higher in breast cases compared to head and neck irradiation (-2.8±15.4% and 0.2±8.2% respectively; Mann-Whitney U test: p=0.002). A comparison between lateral head and neck fields and tangential breast fields revealed that the latter was associated with larger dose discrepancies (-2.2 ± 4.6% vs -3.5 ± 5.7% respectively; Mann-Whitney U test: p=0.029). CONCLUSIONS The results indicate the superiority of monoisocentric technique compared to the rotating couch technique in terms of dose delivery accuracy for treatments with field junctioning planning techniques.
Collapse
Affiliation(s)
- Stefanos Diamantopoulos
- Second Department of Radiology, Medical School, University of Athens, University General Hospital "Attikon", Athens, Greece
| | | | | | | | | | | | | |
Collapse
|
6
|
Ulkowski P, Bulski W, Chełmiński K. Long-term stability of radiotherapy dosimeters calibrated at the Polish Secondary Standard Dosimetry Laboratory. Appl Radiat Isot 2015; 104:181-5. [PMID: 26183579 DOI: 10.1016/j.apradiso.2015.04.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Revised: 02/19/2015] [Accepted: 04/16/2015] [Indexed: 11/16/2022]
Abstract
Unidos 10001, Unidos E (10008/10009) and Dose 1 electrometers from 14 radiotherapy centres were calibrated 3-4 times over a long period of time, together with Farmer type (PTW 30001, 30013, Nuclear Enterprises 2571 and Scanditronix-Wellhofer FC65G) cylindrical ionization chambers and plane-parallel type chambers (PTW Markus 23343 and Scanditronix-Wellhofer PPC05). On the basis of the long period of repetitive establishing of calibration coefficients for the same electrometers and ionization chambers, the accuracy of electrometers and the long-term stability of ionization chambers were examined. All measurements were carried out at the same laboratory, by the same staff, according to the same IAEA recommendations. A good accuracy and long-term stability of the dosimeters used in Polish radiotherapy centres was observed. These values were within 0.1% for electrometers and 0.2% for the chambers with electrometers. Furthermore, these values were not observed to vary over time. The observations confirm the opinion that the requirement of calibration of the dosimeters more often than every 2 years is not justified.
Collapse
Affiliation(s)
- Piotr Ulkowski
- Department of Medical Physics, The Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland
| | - Wojciech Bulski
- Department of Medical Physics, The Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
| | - Krzysztof Chełmiński
- Department of Medical Physics, The Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
| |
Collapse
|
7
|
Chung Y, Kim JW, Shin KH, Kim SS, Ahn SJ, Park W, Lee HS, Kim DW, Lee KC, Suh HS, Kim JH, Shin HS, Kim YB, Suh CO. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study. Int J Radiat Oncol Biol Phys 2015; 91:419-26. [PMID: 25636764 DOI: 10.1016/j.ijrobp.2014.10.022] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2014] [Revised: 10/03/2014] [Accepted: 10/10/2014] [Indexed: 11/17/2022]
Abstract
PURPOSE The Korean Radiation Oncology Group (KROG) 08-06 study protocol allowed radiation therapy (RT) technique to include or exclude breast cancer patients from receiving radiation therapy to the internal mammary lymph node (IMN). The purpose of this study was to assess dosimetric differences between the 2 groups and potential influence on clinical outcome by a dummy run procedure. METHODS AND MATERIALS All participating institutions were asked to produce RT plans without irradiation (Arm 1) and with irradiation to the IMN (Arm 2) for 1 breast-conservation treatment case (breast-conserving surgery [BCS]) and 1 mastectomy case (modified radical mastectomy [MRM]) whose computed tomography images were provided. We assessed interinstitutional variations in IMN delineation and evaluated the dose-volume histograms of the IMN and normal organs. A reference IMN was delineated by an expert panel group based on the study guidelines. Also, we analyzed the potential influence of actual dose variation observed in this study on patient survival. RESULTS Although physicians intended to exclude the IMN within the RT field, the data showed almost 59.0% of the prescribed dose was delivered to the IMN in Arm 1. However, the mean doses covering the IMN in Arm 1 and Arm 2 were significantly different for both cases (P<.001). Due to the probability of overdose in Arm 1, the estimated gain in 7-year disease-free survival rate would be reduced from 10% to 7.9% for BCS cases and 7.1% for MRM cases. The radiation doses to the ipsilateral lung, heart, and coronary artery were lower in Arm 1 than in Arm 2. CONCLUSIONS Although this dummy run study indicated that a substantial dose was delivered to the IMN, even in the nonirradiation group, the dose differences between the 2 groups were statistically significant. However, this dosimetric profile should be studied further with actual patient samples and be taken into consideration when analyzing clinical outcomes according to IMN irradiation.
Collapse
Affiliation(s)
- Yoonsun Chung
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
| | - Jun Won Kim
- Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Kyung Hwan Shin
- Department of Radiation Oncology, Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Su Ssan Kim
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea
| | - Sung-Ja Ahn
- Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea
| | - Won Park
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Hyung-Sik Lee
- Department of Radiation Oncology, Dong-A University Hospital, Dong-A University School of Medicine, Busan, Korea
| | - Dong Won Kim
- Department of Radiation Oncology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea
| | - Kyu Chan Lee
- Department of Radiation Oncology, Gachon University Gil Medical Center, Incheon, Korea
| | - Hyun Suk Suh
- Department of Radiation Oncology, Ewha Womans University Mokdong Hospital, Seoul, Korea
| | - Jin Hee Kim
- Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
| | - Hyun Soo Shin
- Department of Radiation Oncology, Bundang CHA Hospital, School of Medicine, CHA University, Seongnam, Korea
| | - Yong Bae Kim
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
| | - Chang-Ok Suh
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
| |
Collapse
|
8
|
Gershkevitsh E, Pesznyak C, Petrovic B, Grezdo J, Chelminski K, do Carmo Lopes M, Izewska J, Van Dyk J. Dosimetric inter-institutional comparison in European radiotherapy centres: Results of IAEA supported treatment planning system audit. Acta Oncol 2014; 53:628-36. [PMID: 24164104 DOI: 10.3109/0284186x.2013.840742] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND AND PURPOSE One of the newer audit modalities operated by the International Atomic Energy Agency (IAEA) involves audits of treatment planning systems (TPS) in radiotherapy. The main focus of the audit is the dosimetry verification of the delivery of a radiation treatment plan for three-dimensional (3D) conformal radiotherapy using high energy photon beams. The audit has been carried out in eight European countries - Estonia, Hungary, Latvia, Lithuania, Serbia, Slovakia, Poland and Portugal. The corresponding results are presented. MATERIAL AND METHODS The TPS audit reviews the dosimetry, treatment planning and radiotherapy delivery processes using the 'end-to-end' approach, i.e. following the pathway similar to that of the patient, through imaging, treatment planning and dose delivery. The audit is implemented at the national level with IAEA assistance. The national counterparts conduct the TPS audit at local radiotherapy centres through on-site visits. TPS calculated doses are compared with ion chamber measurements performed in an anthropomorphic phantom for eight test cases per algorithm/beam. A set of pre-defined agreement criteria is used to analyse the performance of TPSs. RESULTS TPS audit was carried out in 60 radiotherapy centres. In total, 190 data sets (combination of algorithm and beam quality) have been collected and reviewed. Dosimetry problems requiring interventions were discovered in about 10% of datasets. In addition, suboptimal beam modelling in TPSs was discovered in a number of cases. CONCLUSIONS The TPS audit project using the IAEA methodology has verified the treatment planning system calculations for 3D conformal radiotherapy in a group of radiotherapy centres in Europe. It contributed to achieving better understanding of the performance of TPSs and helped to resolve issues related to imaging, dosimetry and treatment planning.
Collapse
Affiliation(s)
- Eduard Gershkevitsh
- North Estonia Medical Centre, Department of Radiotherapy , Tallinn , Estonia
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Djordjevic M, Sjöholm E, Tullgren O, Sorcini B. Assessment of residual setup errors for anatomical sub-structures in image-guided head-and-neck cancer radiotherapy. Acta Oncol 2014; 53:646-53. [PMID: 24313389 DOI: 10.3109/0284186x.2013.862593] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
BACKGROUND To quantify residual setup errors (RSE) and required planning target volumes (PTV) margins in head-and-neck cancer (HNC) radiotherapy when using daily image guidance (IG) and less-than-daily IG protocols. MATERIAL AND METHODS Daily on-line kV-image registrations of 80 HNC patients (2640 imaged treatment fractions) were retrospectively studied to analyze RSE. Less-than-daily imaging protocols, using different action levels, were simulated on the data. To quantify local RSE; single rigid bony structures were defined as landmarks. The RSEs and required PTV margins were computed for each sub-structure with and without daily IG. RESULTS For less-than-daily IG protocols the setup accuracy was more dependent on frequent imaging throughout the treatment course than the number of initially imaged fractions. With daily IG the RSE of the sub-structures ranged from 0.6 mm to 2.3 mm (systematic) and from 1.0 mm to 1.7 mm (random). Required PTV margins for the sub-regions ranged from 4.5 mm to 9.3 mm with no IG and from 2.3 mm to 6.8 mm with daily IG. CONCLUSION Anatomical changes over the treatment course require frequent IG to achieve accurate dose delivery using highly conformal radiotherapy techniques. The current study shows that considerable local RSE may remain even with daily IGRT. The comprehension of local RSEs in HNC radiotherapy is important when designating PTV margins as well as tolerance levels for couch correction and plan adaption.
Collapse
Affiliation(s)
- Milos Djordjevic
- Department of Medical Physics, Karolinska University Hospital , Stockholm , Sweden
| | | | | | | |
Collapse
|
10
|
Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Fastner G, Feyer P, Fietkau R, Haase W, Harms W, Souchon R, Wenz F, Sauer R. DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 2014; 189:825-33. [PMID: 24002382 PMCID: PMC3825416 DOI: 10.1007/s00066-013-0437-8] [Citation(s) in RCA: 88] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Background and purpose The aim of the present paper is to update the practical guidelines for postoperative adjuvant radiotherapy of breast cancer published in 2007 by the breast cancer expert panel of the German Society for Radiooncology (Deutsche Gesellschaft für Radioonkologie, DEGRO). The present recommendations are based on a revision of the German interdisciplinary S-3 guidelines published in July 2012. Methods A comprehensive survey of the literature concerning radiotherapy following breast conserving therapy (BCT) was performed using the search terms “breast cancer”, “radiotherapy”, and “breast conserving therapy”. Data from lately published meta-analyses, recent randomized trials, and guidelines of international breast cancer societies, yielding new aspects compared to 2007, provided the basis for defining recommendations according to the criteria of evidence-based medicine. In addition to the more general statements of the DKG (Deutsche Krebsgesellschaft), this paper addresses indications, target definition, dosage, and technique of radiotherapy of the breast after conservative surgery for invasive breast cancer. Results Among numerous reports on the effect of radiotherapy during BCT published since the last recommendations, the recent EBCTCG report builds the largest meta-analysis so far available. In a 15 year follow-up on 10,801 patients, whole breast irradiation (WBI) halves the average annual rate of disease recurrence (RR 0.52, 0.48–0.56) and reduces the annual breast cancer death rate by about one sixth (RR 0.82, 0.75–0.90), with a similar proportional, but different absolute benefit in prognostic subgroups (EBCTCG 2011). Furthermore, there is growing evidence that risk-adapted dose augmentation strategies to the tumor bed as well as the implementation of high precision RT techniques (e.g., intraoperative radiotherapy) contribute substantially to a further reduction of local relapse rates. A main focus of ongoing research lies in partial breast irradiation strategies as well as WBI hypofractionation schedules. The potential of both in replacing normofractionated WBI has not yet been finally clarified. Conclusion After breast conserving surgery, no subgroup even in low risk patients has yet been identified for whom radiotherapy can be safely omitted without compromising local control and, hence, cancer-specific survival. In most patients, this translates into an overall survival benefit.
Collapse
Affiliation(s)
- F Sedlmayer
- Department of Radiotherapy and Radiation Oncology, LKH Salzburg, Paracelsus Medical University Hospital, Muellner Haupstr. 48, Salzburg, Austria,
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Matsuo Y, Onishi H, Nakagawa K, Nakamura M, Ariji T, Kumazaki Y, Shimbo M, Tohyama N, Nishio T, Okumura M, Shirato H, Hiraoka M. Guidelines for respiratory motion management in radiation therapy. J Radiat Res 2013; 54:561-8. [PMID: 23239175 PMCID: PMC3650747 DOI: 10.1093/jrr/rrs122] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/21/2012] [Accepted: 11/21/2012] [Indexed: 05/19/2023]
Abstract
Respiratory motion management (RMM) systems in external and stereotactic radiotherapies have been developed in the past two decades. Japanese medical service fee regulations introduced reimbursement for RMM from April 2012. Based on thorough discussions among the four academic societies concerned, these Guidelines have been developed to enable staff (radiation oncologists, radiological technologists, medical physicists, radiotherapy quality managers, radiation oncology nurses, and others) to apply RMM to radiation therapy for tumors subject to respiratory motion, safely and appropriately.
Collapse
Affiliation(s)
- Yukinori Matsuo
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto-shi, Kyoto 606-8507, Japan
| | - Hiroshi Onishi
- Department of Radiology, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan
| | - Keiichi Nakagawa
- Department of Radiology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
| | - Mitsuhiro Nakamura
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto-shi, Kyoto 606-8507, Japan
- Corresponding author. Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto-shi, Kyoto 606-8507, Japan. Tel: +81-75-751-3762; Fax: +81-75-771-9749;
| | - Takaki Ariji
- Department of Radiology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba 277–8577, Japan
| | - Yu Kumazaki
- Department of Radiation Oncology, Saitama Medical University International Medical Center, 1397–1 Yamane, Hidaka-shi, Saitama 350-1298, Japan
| | - Munefumi Shimbo
- Department of Radiology, Saitama Medical Center, 1981 Kamoda, Kawagoe-shi, Saitama 350–8550, Japan
| | - Naoki Tohyama
- Division of Radiation Oncology, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba 260-8717, Japan
| | - Teiji Nishio
- Particle Therapy Division, Research Center for Innovative Oncology, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba 277-8577, Japan
| | - Masahiko Okumura
- Department of Central Radiological Service, Kinki University School of Medicine, 377-2 Ohno-higashi, Osakasayama-shi, Osaka, 589-8511, Japan
| | - Hiroki Shirato
- Department of Radiation Medicine, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-5, Kita-ku, Sapporo-shi, Hokkaido 060-8638, Japan
| | - Masahiro Hiraoka
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto-shi, Kyoto 606-8507, Japan
| |
Collapse
|
12
|
Kim J, Chung J, Park Y, Song J, Kim SK, Ahn SH, Choi CH, Choi WH, Cho B, Ju SG, Kim SJ, Ye S. A multi-institutional study for tolerance and action levels of IMRT dose quality assurance measurements in Korea. J Appl Clin Med Phys 2013; 14:3964. [PMID: 23470928 PMCID: PMC5714373 DOI: 10.1120/jacmp.v14i2.3964] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2012] [Revised: 07/26/2012] [Accepted: 11/13/2012] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to suggest tolerance levels for IMRT DQA measurements using confidence limits determined by a multi-institutional study in Korea. Ten institutions were grouped into LINAC (seven linear accelerators) and TOMO (three tomotherapy machines). The DQA processes consisted of point (high- and low-dose regions) and planar (per-field and composite-field) dose measurements using an ion chamber and films (or 2D detector array) inserted into a custom-made acryl phantom (LINAC) or a cheese phantom (TOMO). The five mock structures developed by AAPM TG-119 were employed, but the prostate as well as the H&N structures were modified according to Korean patients' anatomy. The point measurements were evaluated in a ratio of measured and planned doses, while the planar dose distributions were assessed using two gamma criteria of 2 mm/2% and 3 mm/3%. The confidence limit (|mean + 1.96 σ|) for point measurements was determined to be 3.0% in high-dose regions and 5.0% in low-dose regions. The average percentage of points passing the gamma criteria of 2 mm/2% and 3mm/3% for per-field measurements was 92.7 ± 6.5% and 98.2 ± 2.8%, respectively. Thus, the corresponding confidence limit was 79.1% and 92.7%, respectively. The gamma passing rate averaged over all mock tests and institutions for composite-field measurements was 86.1 ± 6.5% at 2 mm/2% and 95.3 ± 3.8% at 3 mm/3%, leading to the confidence limit of 73.3% and 87.9%, respectively. There was no significant difference in the tolerance levels of point dose measurements between LINAC and TOMO groups. In spite of the differences in mock structures and dosimetry tools, our tolerance levels were comparable to those of AAPM and ESTRO guidelines.
Collapse
Affiliation(s)
- Jung‐in Kim
- Interdisciplinary Program in Radiation Applied Life Science and Institute of Radiation MedicineCollege of Medicine, Seoul National UniversitySeoul
- Department of Radiation OncologyKangBuk Samsung Medical CenterSeoul
| | - Jin‐Beom Chung
- Department of Radiation OncologySeoul National University Bundang HospitalSeongnam
| | - Yang‐Kyun Park
- Department of Radiation OncologySeoul National University HospitalSeoul
| | - Ju‐Young Song
- Department of Radiation OncologyChonnam National University Medical SchoolHwasun
| | - Sung Kyu Kim
- Department of Therapeutic Radiology & OncologyYeungnam UniversitySeoul
| | - Sung Hwan Ahn
- Department of Radiation OncologyDong‐A University Medical CenterBusan
| | - Chang Heon Choi
- Department of Radiation OncologyJeju National University HospitalJeju
| | - Won Hoon Choi
- Department of Radiation OncologyYonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health SystemSeoul
| | - Byungchul Cho
- Department of Radiation OncologyAsan Medical Center, University of Ulsan College of MedicineSeoul
| | - Sang Gyu Ju
- Department of Radiation OncologySeoul Samsung Medical CenterSeoul
| | - Sung Jin Kim
- Department of Radiation OncologyEulji University HospitalDaejon
| | - Sung‐Joon Ye
- Department of Radiation OncologySeoul National University HospitalSeoul
- Department of Transdisciplinary Studies and Advanced Institutes of Convergence TechnologySeoul National UniversitySuwonKorea
| |
Collapse
|
13
|
Lee TF, Ting HM, Chao PJ, Wang HY, Shieh CS, Horng MF, Wu JM, Yeh SA, Cho MY, Huang EY, Huang YJ, Chen HC, Fang FM. Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose-volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancer. Br J Radiol 2012; 85:1499-506. [PMID: 23091290 PMCID: PMC3500793 DOI: 10.1259/bjr/24112047] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2011] [Revised: 03/08/2012] [Accepted: 03/19/2012] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVE We compared and evaluated the differences between two models for treating bilateral breast cancer (BBC): (i) dose-volume-based intensity-modulated radiation treatment (DV plan), and (ii) dose-volume-based intensity-modulated radiotherapy with generalised equivalent uniform dose-based optimisation (DV-gEUD plan). METHODS The quality and performance of the DV plan and DV-gEUD plan using the Pinnacle(3) system (Philips, Fitchburg, WI) were evaluated and compared in 10 patients with stage T2-T4 BBC. The plans were delivered on a Varian 21EX linear accelerator (Varian Medical Systems, Milpitas, CA) equipped with a Millennium 120 leaf multileaf collimator (Varian Medical Systems). The parameters analysed included the conformity index, homogeneity index, tumour control probability of the planning target volume (PTV), the volumes V(20 Gy) and V(30 Gy) of the organs at risk (OAR, including the heart and lungs), mean dose and the normal tissue complication probability. RESULTS Both plans met the requirements for the coverage of PTV with similar conformity and homogeneity indices. However, the DV-gEUD plan had the advantage of dose sparing for OAR: the mean doses of the heart and lungs, lung V(20) (Gy), and heart V(30) (Gy) in the DV-gEUD plan were lower than those in the DV plan (p<0.05). CONCLUSIONS A better result can be obtained by starting with a DV-generated plan and then improving it by adding gEUD-based improvements to reduce the number of iterations and to improve the optimum dose distribution. Advances to knowledge The DV-gEUD plan provided superior dosimetric results for treating BBC in terms of PTV coverage and OAR sparing than the DV plan, without sacrificing the homogeneity of dose distribution in the PTV.
Collapse
Affiliation(s)
- T-F Lee
- Medical Physics & Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, Kaohsiung, Taiwan.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Park JY, Lee JW, Chung JB, Choi KS, Kim YL, Park BM, Kim Y, Kim J, Choi J, Kim JS, Hong S, Suh TS. Radiobiological model-based bio-anatomical quality assurance in intensity-modulated radiation therapy for prostate cancer. J Radiat Res 2012; 53:978-988. [PMID: 22915778 PMCID: PMC3483850 DOI: 10.1093/jrr/rrs049] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/18/2012] [Revised: 06/11/2012] [Accepted: 06/12/2012] [Indexed: 06/01/2023]
Abstract
A bio-anatomical quality assurance (QA) method employing tumor control probability (TCP) and normal tissue complication probability (NTCP) is described that can integrate radiobiological effects into intensity-modulated radiation therapy (IMRT). We evaluated the variations in the radiobiological effects caused by random errors (r-errors) and systematic errors (s-errors) by evaluating TCP and NTCP in two groups: patients with an intact prostate (G(intact)) and those who have undergone prostatectomy (G(tectomy)). The r-errors were generated using an isocenter shift of ±1 mm to simulate a misaligned patient set-up. The s-errors were generated using individual leaves that were displaced inwardly and outwardly by 1 mm on multileaf collimator field files. Subvolume-based TCP and NTCP were visualized on computed tomography (CT) images to determine the radiobiological effects on the principal structures. The bio-anatomical QA using the TCP and NTCP maps differentiated the critical radiobiological effects on specific volumes, particularly at the anterior rectal walls and planning target volumes. The s-errors showed a TCP variation of -40-25% in G(tectomy) and -30-10% in G(intact), while the r-errors were less than 1.5% in both groups. The r-errors for the rectum and bladder showed higher NTCP variations at ±20% and ±10%, respectively, and the s-errors were greater than ±65% for both. This bio-anatomical method, as a patient-specific IMRT QA, can provide distinct indications of clinically significant radiobiological effects beyond the minimization of probable physical dose errors in phantoms.
Collapse
Affiliation(s)
- Ji-Yeon Park
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
| | - Jeong-Woo Lee
- Research Institute of Health Science, College of Health Science, Korea University, Seoul 136-703, Korea
- Department of Radiation Oncology, Konkuk University Medical Center, Seoul 143-729, Korea
| | - Jin-Beom Chung
- Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea
| | - Kyoung-Sik Choi
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
- Department of Radiation Oncology, Anyang SAM Hospital, Anyang 430-733, Korea
| | - Yon-Lae Kim
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
- Department of Radiology, Choonhae College of Health Science, Ulsan 689-784, Korea
| | - Byung-Moon Park
- Department of Radiation Oncology, Konkuk University Medical Center, Seoul 143-729, Korea
| | - Youhyun Kim
- Department of Radiologic Science, College of Health Science, Korea University, Seoul 136-703, Korea
| | - Jungmin Kim
- Department of Radiologic Science, College of Health Science, Korea University, Seoul 136-703, Korea
| | - Jonghak Choi
- Department of Radiologic Science, College of Health Science, Korea University, Seoul 136-703, Korea
| | - Jae-Sung Kim
- Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea
| | - Semie Hong
- Department of Radiation Oncology, Konkuk University Medical Center, Seoul 143-729, Korea
| | - Tae-Suk Suh
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
| |
Collapse
|
15
|
Mizowaki T, Hatano K, Hiraoka M. Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer. J Radiat Res 2012; 53:608-14. [PMID: 22843627 PMCID: PMC3393351 DOI: 10.1093/jrr/rrs016] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/18/2012] [Revised: 03/25/2012] [Accepted: 03/29/2012] [Indexed: 05/24/2023]
Abstract
Intensity-modulated radiation therapy (IMRT) has recently become popular in Japan. Prostate cancer is indisputably one of the main targets of IMRT. However, the current status and interfacility differences in dose-prescription policies for prostate IMRT are unknown. Therefore, a nationwide survey of 43 institutions that had implemented prostate IMRT was conducted by sending a questionnaire regarding the above-mentioned issues. Thirty-three institutions (77%) had responded to the questionnaire by the end of October 2010. A total of 5245 patients with localized prostate cancer had been treated with IMRT by the end of 2009. Regular multileaf collimator-based techniques were the most common beam delivery method. Dose-prescription policies were divided into four major categories: isocenter-based (@isocenter), dose delivered to 95% of the planning target volume (PTV) (D95)-based (D95@PTV), mean dose to the PTV-based (Mean@PTV), and mean dose to the clinical target volume (CTV)-based (@CTV). The mean doses of the CTV and PTV, and the volume of the PTV receiving 95% of the dose (V95) were significantly higher with the D95@PTV policy than with the other prescription policies. Low-dose areas and hot spots were observed within the PTV in plans with @isocenter and @CTV policies. In conclusion, there are currently considerable differences among institutions in Japan regarding target doses for prostate IMRT. The D95@PTV prescription policy resulted in significant dose escalation compared with the other policies. These differences should be taken into consideration when interpreting treatment outcomes and creating multi-institutional protocols in the future.
Collapse
Affiliation(s)
- Takashi Mizowaki
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan.
| | | | | |
Collapse
|
16
|
Althof V, van Haaren P, Westendorp R, Nuver T, Kramer D, Ikink M, Bel A, Minken A. A quality assurance tool for helical tomotherapy using a step-wedge phantom and the on-board MVCT detector. J Appl Clin Med Phys 2012; 13:3585. [PMID: 22231210 PMCID: PMC5716125 DOI: 10.1120/jacmp.v13i1.3585] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2011] [Revised: 08/25/2011] [Accepted: 08/19/2011] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to develop and evaluate filmless quality assurance (QA) tools for helical tomotherapy by using the signals from the on-board megavoltage computed tomography (MVCT) detector and applying a dedicated step-wedge phantom. The step-wedge phantom is a 15 cm long step-like aluminum block positioned on the couch. The phantom was moved through the slit beam and MVCT detector signals were analyzed. Two QA procedures were developed, with gantry fixed at 0°: 1) step-wedge procedure: to check beam energy consistency, field width, laser alignment with respect to the virtual isocenter, couch movement, and couch velocity; and 2) completion procedure: to check the accuracy of a field abutment made by the tomotherapy system after a treatment interruption. The procedures were designed as constancy tool and were validated by measurement of deliberately induced variations and comparison with a reference method. Two Hi-Art II machines were monitored over a period of three years using the step-wedge procedures. The data acquisition takes 5 minutes. The analysis is fully automated and results are available directly after acquisition. Couch speed deviations up to 2% were induced. The mean absolute difference between expected and measured couch speed was 0.2% ± 0.2% (1 standard deviation SD). Field width was varied around the 10 mm nominal size, between 9.7 and 11.1 mm, in steps of 0.2 mm. Mean difference between the step-wedge analysis and the reference method was < 0.01 mm ± 0.03 mm (1 SD). Laser (mis)alignment relative to a reference situation was detected with 0.3 mm precision (1SD). The step-wedge profile was fitted to a PDD in water. The PDD ratio D20/D10, measured at depths of 20 cm and 10 cm, was used to check beam energy consistency. Beam energy variations were induced. Mean difference between step-wedge and water PDD ratios was 0.2% ± 0.3% (1SD). The completion procedure was able to reveal abutment mismatches with a mean error of -0.6 mm ± 0.2 mm (1SD). The trending data over a period of three years showed a mean deviation of 0.4% ± 0.1% (1 SD) in couch speed. The spread in field width was 0.15 mm (1 SD). The sagittal and transverse lasers showed a variation of 0.5 mm (1 SD). Beam energy varied 1.0% (1 SD). A mean abutment mismatch was found of -0.4 mm ± 0.2 mm (1 SD) between interrupted treatments. The on-board MVCT detector, in combination with the step-wedge phantom, is a suitable tool for a QA program for helical tomotherapy. The method allowed frequent monitoring of machine behavior for the past three years.
Collapse
Affiliation(s)
- Vincent Althof
- Radiotherapeutic Institute RISO, Deventer, The Netherlands.
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Affiliation(s)
- Arthur J Olch
- University of Southern California Keck School of Medicine and Children's Hospital Los Angeles, Radiation Oncology Program, Los Angeles, California 90027, USA.
| |
Collapse
|
18
|
Zhu XR, Poenisch F, Song X, Johnson JL, Ciangaru G, Taylor MB, Lii M, Martin C, Arjomandy B, Lee AK, Choi S, Nguyen QN, Gillin MT, Sahoo N. Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose. Int J Radiat Oncol Biol Phys 2011; 81:552-9. [PMID: 21300457 DOI: 10.1016/j.ijrobp.2010.11.071] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2010] [Revised: 11/08/2010] [Accepted: 11/22/2010] [Indexed: 12/21/2022]
Abstract
PURPOSE To describe our experiences with patient-specific quality assurance (QA) for patients with prostate cancer receiving spot scanning proton therapy (SSPT) using single-field uniform dose (SFUD). METHODS AND MATERIALS The first group of 249 patients with prostate cancer treated with SSPT using SFUD was included in this work. The scanning-beam planning target volume and number of monitor units were recorded and checked for consistency. Patient-specific dosimetric measurements were performed, including the point dose for each plan, depth doses, and two-dimensional (2D) dose distribution in the planes perpendicular to the incident beam direction for each field at multiple depths. The γ-index with 3% dose or 3-mm distance agreement criteria was used to evaluate the 2D dose distributions. RESULTS We observed a linear relationship between the number of monitor units and scanning-beam planning target volume. The difference between the measured and calculated point doses (mean ± SD) was 0.0% ± 0.7% (range, -2.9% to 1.8%). In general, the depth doses exhibited good agreement except at the distal end of the spread-out Bragg peak. The pass rate of γ-index (mean ± SD) for 2D dose comparison was 96.2% ± 2.6% (range, 90-100%). Discrepancies between the measured and calculated dose distributions primarily resulted from the limitation of the model used by the treatment planning system. CONCLUSIONS We have established a patient-specific QA program for prostate cancer patients receiving SSPT using SFUD.
Collapse
Affiliation(s)
- X Ronald Zhu
- Department of Radiation Physics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Mavroidis P, Shi C, Plataniotis GA, Delichas MG, Ferreira BC, Rodriguez S, Lind BK, Papanikolaou N. Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy. Br J Radiol 2011; 84:161-72. [PMID: 20858664 PMCID: PMC3473851 DOI: 10.1259/bjr/89275085] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2009] [Revised: 01/26/2010] [Accepted: 03/03/2010] [Indexed: 12/25/2022] Open
Abstract
OBJECTIVES The aim of this study was to compare three-dimensional (3D) conformal radiotherapy and the two different forms of IMRT in lung cancer radiotherapy. METHODS Cases of four lung cancer patients were investigated by developing a 3D conformal treatment plan, a linac MLC-based step-and-shoot IMRT plan and an HT plan for each case. With the use of the complication-free tumour control probability (P(+)) index and the uniform dose concept as the common prescription point of the plans, the different treatment plans were compared based on radiobiological measures. RESULTS The applied plan evaluation method shows the MLC-based IMRT and the HT treatment plans are almost equivalent over the clinically useful dose prescription range; however, the 3D conformal plan inferior. At the optimal dose levels, the 3D conformal treatment plans give an average P(+) of 48.1% for a effective uniform dose to the internal target volume (ITV) of 62.4 Gy, whereas the corresponding MLC-based IMRT treatment plans are more effective by an average ΔP(+) of 27.0% for a Δ effective uniform dose of 16.3 Gy. Similarly, the HT treatment plans are more effective than the 3D-conformal plans by an average ΔP(+) of 23.8% for a Δ effective uniform dose of 11.6 Gy. CONCLUSION A radiobiological treatment plan evaluation can provide a closer association of the delivered treatment with the clinical outcome by taking into account the dose-response relations of the irradiated tumours and normal tissues. The use of P - effective uniform dose diagrams can complement the traditional tools of evaluation to compare and effectively evaluate different treatment plans.
Collapse
Affiliation(s)
- P Mavroidis
- Department of Medical Radiation Physics, Karolinska Institutet, Stockholm University, Sweden.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Abstract
PURPOSE Dose painting strategies are limited by optimization algorithms in treatment planning systems and physical constraints of the beam delivery. We investigate dose conformity using the RapidArc optimizer and beam delivery technique. Furthermore, robustness of the plans with respect to positioning uncertainties are evaluated. METHODS A head & neck cancer patient underwent a [(61)Cu]Cu-ATSM PET/CT-scan. PET-SUVs were converted to prescribed dose with a base dose of 60 Gy, and target mean dose 90 Gy. The voxel-based prescription was converted into 3, 5, 7, 9, and 11 discrete prescription levels. Optimization was performed in Eclipse, varying the following parameters: MLC leaf width (5 mm and 2.5 mm), number of arcs (1 and 2) and collimator rotation (0, 15, 30 and 45 degrees). Dose conformity was evaluated using quality volume histograms (QVHs), and relative volumes receiving within ±5% of prescribed dose (Q(0.95-1.05)). Deliverability was tested using a Delta4(®) phantom. Robustness was tested by shifting the isocenter 1 mm and 2 mm in all directions, and recalculating the dose. RESULTS Good conformity was obtained using MLC leaf width 2.5 mm, two arcs, and collimators 45/315 degrees, with Q(0.95-1.05)=92.8%, 91.6%, 89.7% and 84.6%. Using only one arc or increasing the MLC leaf width had a small deteriorating effect of 2-5%. Small changes in collimator angle gave small changes, but large changes in collimator angle gave a larger decrease in plan conformity; for angles of 15 and 0 degrees (two arcs, 2.5 mm leaf width), Q(0.95-1.05) decreased by up to 15%. Consistency between planned and delivered dose was good, with ∼90% of gamma values <1. For 1 mm shift, Q(0.95-1.05) was decreased by 5-15%, while for 2 mm shift, Q(0.95-1.05) was decreased to 55-60%. CONCLUSIONS Results demonstrate feasibility of planning of prescription doses with multiple levels for dose painting using RapidArc, and plans were deliverable. Robustness to positional error was low.
Collapse
Affiliation(s)
- Stine S Korreman
- University of Wisconsin School of Medicine and Public Health, Department of Human Oncology, Clinical Sciences Center, Madison, Wisconsin, USA.
| | | | | | | | | | | |
Collapse
|
21
|
Vogelius IS, Westerly DC, Cannon GM, Bentzen SM. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol 2010; 49:1052-7. [PMID: 20831495 DOI: 10.3109/0284186x.2010.498835] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
PURPOSE To study the interaction between radiation dose distribution and hypofractionated radiotherapy with respect to the risk of radiation pneumonitis (RP) estimated from normal tissue complication probability (NTCP) models. MATERIAL AND METHODS Eighteen non-small cell lung cancer patients previously treated with helical tomotherapy were selected. For each patient a 3D-conformal plan (3D-CRT) plan was produced in addition to the delivered plan. The standard fractionation schedule was set to 60 Gy in 30 fractions. Iso-efficacy comparisons with hypofractionation were performed by changing the fractionation and the physical prescription dose while keeping the equivalent tumor dose in 2 Gy fractions constant. The risk of developing RP after radiotherapy was estimated using the Mean Equivalent Lung Dose in 2-Gy fractions (MELD(2)) NTCP model with α/β=4 Gy for the residual lung. Overall treatment time was kept constant. RESULTS The mean risk of clinical RP after standard fractionation was 7.6% for Tomotherapy (range: 2.8-15.9%) and 9.2% for 3D-CRT (range 3.2-20.2%). Changing to 20 fractions, the Tomotherapy plans became slightly less toxic if the tumor α/β ratio, (α/β)(T), was 7 Gy (mean RP risk 7.5%, range 2.8-16%) while the 3D-CRT plans became marginally more toxic (mean RP risk 9.8%, range 3.2-21%). If (α/β)(T) was 13 Gy, the mean estimated risk of RP is 7.9% for Tomotherapy (range: 2.8-17%) and 10% for 3D-CRT (range 3.2-22%). CONCLUSION Modern highly conformal dose distributions are radiobiologically more forgiving with respect to hypofractionation, even for a normal tissue endpoint where α/β is lower than for the tumor in question.
Collapse
MESH Headings
- Calibration
- Carcinoma, Non-Small-Cell Lung/diagnostic imaging
- Carcinoma, Non-Small-Cell Lung/radiotherapy
- Dose Fractionation, Radiation
- Down-Regulation
- Humans
- Lung Neoplasms/diagnostic imaging
- Lung Neoplasms/radiotherapy
- Radiation Dosage
- Radiation Pneumonitis/etiology
- Radiation Tolerance
- Radiotherapy Planning, Computer-Assisted/methods
- Radiotherapy Planning, Computer-Assisted/standards
- Radiotherapy, Conformal/adverse effects
- Radiotherapy, Conformal/methods
- Radiotherapy, Conformal/standards
- Risk Factors
- Social Change
- Therapeutic Equivalency
- Tomography, Spiral Computed/methods
- Tomography, Spiral Computed/standards
Collapse
Affiliation(s)
- Ivan S Vogelius
- Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
| | | | | | | |
Collapse
|
22
|
Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 2009; 73:9-14. [PMID: 19100920 DOI: 10.1016/j.ijrobp.2008.04.049] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2008] [Revised: 04/25/2008] [Accepted: 04/27/2008] [Indexed: 12/15/2022]
Affiliation(s)
- Alan C Hartford
- Section of Radiation Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Peace T, Subramanian B, Ravindran P. An experimental study on using a diagnostic computed radiography system as a quality assurance tool in radiotherapy. Australas Phys Eng Sci Med 2008; 31:226-34. [PMID: 18946982 DOI: 10.1007/bf03179349] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The advent of improved digital imaging modalities in diagnostic and therapy is fast making conventional films a nonexistent entity. However, several radiotherapy centers still persist with film for performing quality assurance (QA) tests. This paper investigates the feasibility of using a diagnostic computed radiography (CR) system as a QA tool in radiotherapy. QA tests such as light field congruence, field size verification, determination of radiation isocentre size, multileaf collimator (MLC) check and determination of isocentric shift for stereotactic radiosurgery (SRS) were performed and compared with film. The maximum variation observed between CR and film was 0.4 mm for field size verification, -0.13 mm for the radiation isocentre size check, 0.77 for MLC check and -0.1 mm for isocentric shift using the Winston Lutz test tool for SRS QA. From these results obtained with the CR it is concluded that a diagnostic CR system can be an excellent cost-effective digital alternative to therapy film as a tool for QA in radiotherapy.
Collapse
Affiliation(s)
- T Peace
- Department of Radiotherapy, Christian Medical College, Vellore, India.
| | | | | |
Collapse
|
24
|
Tsougos I, Schreibmann E, Lahanas M, Theodorou K, Kappas C, Baltas D. Geometrical pre-planning for conformal radiotherapy. Acta Oncol 2008; 46:918-27. [PMID: 17851850 DOI: 10.1080/02841860701218600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The optimum selection of beams and arcs in conformal techniques is of the outmost importance in modern radiotherapy. In this work we give a description of an analytic method to aid optimum selection, which is based on minimizing the intersection between beams and organs at risk (OAR) and on minimizing the intersection between the beam and the planning target volume (PTV). An arc-selection function that permits selection of irradiation arcs based on individual beam feasibility is introduce. The method simulates the treatment process by defining a computed beam feasibility, for every possible set of gantry-table angles, by taking into account accurately computer intersection volumes between the OAR and beams. The beams are shaped to conform the target using realistic parameters for the treatment process. The results are displayed on a virtual sphere centred at the isocenter with color-coded regions indicating beam feasibility. Arcs selections are performed by searching the map for successive gantry positions at a certain table angle, with feasibility values greater than a user-specified threshold. The accuracy of the method was confirmed by using geometrical regular shapes, as well as real clinical cases.
Collapse
Affiliation(s)
- Ioannis Tsougos
- Medical Physics Department, Medical School, University Hospital, University of Thessaly, Greece.
| | | | | | | | | | | |
Collapse
|
25
|
Kirova YM, Campana F, Fournier-Bidoz N, Stilhart A, Dendale R, Bollet MA, Fourquet A. Postmastectomy Electron Beam Chest Wall Irradiation in Women With Breast Cancer: A Clinical Step Toward Conformal Electron Therapy. Int J Radiat Oncol Biol Phys 2007; 69:1139-44. [PMID: 17689024 DOI: 10.1016/j.ijrobp.2007.05.007] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2007] [Revised: 04/26/2007] [Accepted: 04/30/2007] [Indexed: 11/18/2022]
Abstract
PURPOSE Electron beam radiotherapy of the chest wall with or without lymph node irradiation has been used at the Institut Curie for >20 years. The purpose of this report was to show the latest improvements of our technique developed to avoid hot spots and improve the homogeneity. METHODS AND MATERIALS The study was split into two parts. A new electron irradiation technique was designed and compared with the standard one (dosimetric study). The dose distributions were calculated using our treatment planning software ISIS (Technologie Diffusion). The dose calculation was performed using the same calculation parameters for the new and standard techniques. Next, the early skin toxicity of our new technique was evaluated prospectively in the first 25 patients using Radiation Therapy Oncology Group criteria (clinical study). RESULTS The maximal dose found on the five slices was 53.4 +/- 1.1 Gy for the new technique and 59.1 +/- 2.3 Gy for the standard technique. The hot spots of the standard technique plans were situated at the overlap between the internal mammary chain and chest wall fields. The use of one unique field that included both chest wall and internal mammary chain volumes solved the problem of junction. To date, 25 patients have been treated with the new technique. Of these patients, 12% developed Grade 0, 48% Grade 1, 32% Grade 2, and 8% Grade 3 toxicity. CONCLUSIONS This report describes an improvement in the standard postmastectomy electron beam technique of the chest wall. This new technique provides improved target homogeneity and conformality compared with the standard technique. This treatment was well tolerated, with a low rate of early toxicity events.
Collapse
Affiliation(s)
- Youlia M Kirova
- Department of Radiation Oncology, Institut Curie, Paris, France.
| | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
The performance of a convolution/superposition based treatment planning system depends on the ability of the dose calculation algorithm to accurately account for physical interactions taking place in the tissue, key components of the linac head and on the accuracy of the photon beam model. Generally the user has little or no control over the performance of the dose calculation algorithm but is responsible for the accuracy of the beam model within the constraints imposed by the system. This study explores the dosimetric impact of limitations in photon beam modeling accuracy on complex 3D clinical treatment plans. A total of 70 photon beam models was created in the Pinnacle treatment planning system. Two of the models served as references for 6 MV and 15 MV beams, while the rest were created by perturbing the reference models in order to produce specific deviations in specific regions of the calculated dose profiles (central axis and transverse). The beam models were then used to generate 3D plans on seven CT data sets each for four different treatment sites (breast and conformal prostate, lung and brain). The equivalent uniform doses (EUD) of the targets and the principal organs at risk (OARs) of all plans ( approximately 1000) were calculated and compared to the EUDs delivered by the reference beam models. In general, accurate dosimetry of the target is most greatly compromised by poor modeling of the central axis depth dose and the horns, while the EUDs of the OARs exhibited the greatest sensitivity to beam width accuracy. Based on the results of this analysis we suggest a set of tolerances to be met during commissioning of the beam models in a treatment planning system that are consistent in terms of clinical outcomes as predicted by the EUD.
Collapse
Affiliation(s)
- A Rangel
- Tom Baker Cancer Centre, Department of Medical Physics, 1331-29 St NW, Calgary, T2N 4N2, Canada
| | | | | | | |
Collapse
|
27
|
Abstract
Assuring quality in the practice of radiation oncology has become increasingly important because of the greater complexity of treatments and the advancing knowledge of the diseases that are treated. Increased public attention to errors in medicine, the increasing use of new imaging modalities to plan therapy, the availability of new therapeutic techniques such as intensity-modulated radiation therapy, and greater dependence on information technology have increased the need for intense quality assurance (QA) in the specialty. The process of QA and the resources available to radiation oncology staff members are described.
Collapse
Affiliation(s)
- Peter R Hulick
- South Suburban Oncology Center, Quincy, Massachusetts 02169, USA.
| | | |
Collapse
|
28
|
Bekelman JE, Zelefsky MJ, Jang TL, Basch EM, Schrag D. Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. Int J Radiat Oncol Biol Phys 2007; 69:1456-66. [PMID: 17689880 PMCID: PMC2267435 DOI: 10.1016/j.ijrobp.2007.05.020] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2007] [Revised: 05/15/2007] [Accepted: 05/16/2007] [Indexed: 10/23/2022]
Abstract
PURPOSE To characterize the variation in adherence to quality measures of external beam radiotherapy (EBRT) for localized prostate cancer and its relation to patient and provider characteristics in a population-based, representative sample of U.S. men. METHODS AND MATERIALS We evaluated EBRT quality measures proposed by a RAND expert panel of physicians among men aged >or=65 years diagnosed between 2000 and 2002 with localized prostate cancer and treated with primary EBRT using data from the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare program. We assessed the adherence to five EBRT quality measures that were amenable to analysis using SEER-Medicare data: (1) use of conformal RT planning; (2) use of high-energy (>10-MV) photons; (3) use of custom immobilization; (4) completion of two follow-up visits with a radiation oncologist in the year after therapy; and (5) radiation oncologist board certification. RESULTS Of the 11,674 patients, 85% had received conformal RT planning, 75% had received high-energy photons, and 97% had received custom immobilization. One-third of patients had completed two follow-up visits with a radiation oncologist, although 91% had at least one visit with a urologist or radiation oncologist. Most patients (85%) had been treated by a board-certified radiation oncologist. CONCLUSIONS The overall high adherence to EBRT quality measures masked substantial variation in geography, socioeconomic status in the area of residence, and teaching affiliation of the RT facility. Future research should examine the reasons for the variations in these measures and whether the variation is associated with important clinical outcomes.
Collapse
Affiliation(s)
- Justin E Bekelman
- Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
| | | | | | | | | |
Collapse
|
29
|
Georg D, Stock M, Kroupa B, Olofsson J, Nyholm T, Ahnesjö A, Karlsson M. Patient-specific IMRT verification using independent fluence-based dose calculation software: experimental benchmarking and initial clinical experience. Phys Med Biol 2007; 52:4981-92. [PMID: 17671348 DOI: 10.1088/0031-9155/52/16/018] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Experimental methods are commonly used for patient-specific intensity-modulated radiotherapy (IMRT) verification. The purpose of this study was to investigate the accuracy and performance of independent dose calculation software (denoted as 'MUV' (monitor unit verification)) for patient-specific quality assurance (QA). 52 patients receiving step-and-shoot IMRT were considered. IMRT plans were recalculated by the treatment planning systems (TPS) in a dedicated QA phantom, in which an experimental 1D and 2D verification (0.3 cm(3) ionization chamber; films) was performed. Additionally, an independent dose calculation was performed. The fluence-based algorithm of MUV accounts for collimator transmission, rounded leaf ends, tongue-and-groove effect, backscatter to the monitor chamber and scatter from the flattening filter. The dose calculation utilizes a pencil beam model based on a beam quality index. DICOM RT files from patient plans, exported from the TPS, were directly used as patient-specific input data in MUV. For composite IMRT plans, average deviations in the high dose region between ionization chamber measurements and point dose calculations performed with the TPS and MUV were 1.6 +/- 1.2% and 0.5 +/- 1.1% (1 S.D.). The dose deviations between MUV and TPS slightly depended on the distance from the isocentre position. For individual intensity-modulated beams (total 367), an average deviation of 1.1 +/- 2.9% was determined between calculations performed with the TPS and with MUV, with maximum deviations up to 14%. However, absolute dose deviations were mostly less than 3 cGy. Based on the current results, we aim to apply a confidence limit of 3% (with respect to the prescribed dose) or 6 cGy for routine IMRT verification. For off-axis points at distances larger than 5 cm and for low dose regions, we consider 5% dose deviation or 10 cGy acceptable. The time needed for an independent calculation compares very favourably with the net time for an experimental approach. The physical effects modelled in the dose calculation software MUV allow accurate dose calculations in individual verification points. Independent calculations may be used to replace experimental dose verification once the IMRT programme is mature.
Collapse
Affiliation(s)
- Dietmar Georg
- Abteilung Medizinische Strahlenphysik, Univ. Klinik für Strahlentherapie, Medizinische Universität Wien/AKH Wien, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
| | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
Quality assurance (QA) systems for intensity-modulated radiation therapy (IMRT) have become standard tools in modern clinical medical physics departments. However, because formalized industry standards or recommendations from professional societies have yet to be defined, methods of IMRT QA analysis vary from institution to institution. Understanding where matters stand today is an important step toward improving the effectiveness of IMRT QA and developing standards. We therefore conducted an IMRT QA survey. This particular survey was limited to users of an electronic two-dimensional diode array device, but we took care to keep the questions as general and useful as possible. The online survey polled institutions (one survey per institution) on a collection of questions about methods of IMRT QA. The topics were general to the IMRT QA analysis methods common to all IMRT systems; none of the questions was vendor- or product-specific. Survey results showed that a significant proportion of responding institutions (32.8%) use the single-gantry-angle composite method for IMRT QA analysis instead of field-by-field analysis. Most institutions perform absolute dose comparisons rather than relative dose comparisons, with the 3% criterion being used most often for the percentage difference analysis, and the 3 mm criterion for distance-to-agreement analysis. The most prevalent standard for acceptance testing is the combined 3% and 3 mm criteria. A significant percentage of responding institutions report not yet having standard benchmarks for acceptance testing-specifically, 26.6%, 35.3%, and 67.6% had not yet established standard acceptance criteria for prostate, head and neck, and breast IMRT respectively. This survey helps in understanding how institutions perform IMRT QA analysis today. This understanding will help to move institutions toward more standardized acceptance testing. But before standards are defined, it would be useful to connect the conventional planar QA analyses to their resulting impact on the overall plan, using clinically relevant metrics (such as estimated deviations in dose-volume histograms).
Collapse
|
31
|
Lehmann J, Perks J, Semon S, Harse R, Purdy JA. Commissioning experience with cone-beam computed tomography for image-guided radiation therapy. J Appl Clin Med Phys 2007; 8:21-36. [PMID: 17712297 PMCID: PMC5722599 DOI: 10.1120/jacmp.v8i3.2354] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2006] [Revised: 03/20/2007] [Accepted: 03/15/2007] [Indexed: 11/23/2022] Open
Abstract
This paper reports on the commissioning of an Elekta cone‐beam computed tomography (CT) system at one of the first U.S. sites to install a “regular,” off‐the‐shelf Elekta Synergy (Elekta, Stockholm, Sweden) accelerator system. We present the quality assurance (QA) procedure as a guide for other users. The commissioning had six elements: (1) system safety, (2) geometric accuracy (agreement of megavoltage and kilovoltage beam isocenters), (3) image quality, (4) registration and correction accuracy, (5) dose to patient and dosimetric stability, and (6) QA procedures. The system passed the safety tests, and agreement of the isocenters was found to be within 1 mm. Using a precisely moved skull phantom, the reconstruction and alignment algorithm was found to be accurate within 1 mm and 1 degree in each dimension. Of 12 measurement points spanning a 9×9×15‐cm volume in a Rando phantom (The Phantom Laboratory, Salem, NY), the average agreement in the x, y, and z coordinates was 0.10 mm, −0.12 mm, and 0.22 mm [standard deviations (SDs): 0.21 mm, 0.55 mm, 0.21 mm; largest deviations: 0.6 mm, 1.0 mm, 0.5 mm] respectively. The larger deviation for the y component can be partly attributed to the CT slice thickness of 1 mm in that direction. Dose to the patient depends on the machine settings and patient geometry. To monitor dose consistency, air kerma (output) and half‐value layer (beam quality) are measured for a typical clinical setting. Air kerma was 6.3 cGy (120 kVp, 40 mA, 40 ms per frame, 360‐degree scan, S20 field of view); half value layer was 7.1 mm aluminum (120 kV, 40 mA). We suggest performing items 1, 2, and 3 monthly, and 4 and 5 annually. In addition, we devised a daily QA procedure to verify agreement of the megavoltage and kilovoltage isocenters using a simple phantom containing three small steel balls. The frequency of all checks will be reevaluated based on data collected during about 1 year. PACS number: 87.53.Xd
Collapse
Affiliation(s)
- Joerg Lehmann
- Department of Radiation OncologyUniversity of California–Davis School of MedicineSacramentoCaliforniaU.S.A.
| | - Julian Perks
- Department of Radiation OncologyUniversity of California–Davis School of MedicineSacramentoCaliforniaU.S.A.
| | - Sheldon Semon
- Department of Radiation OncologyUniversity of California–Davis School of MedicineSacramentoCaliforniaU.S.A.
| | - Rick Harse
- Department of Radiation OncologyUniversity of California–Davis School of MedicineSacramentoCaliforniaU.S.A.
| | - James A. Purdy
- Department of Radiation OncologyUniversity of California–Davis School of MedicineSacramentoCaliforniaU.S.A.
| |
Collapse
|
32
|
Litzenberg DW, Willoughby TR, Balter JM, Sandler HM, Wei J, Kupelian PA, Cunningham AA, Bock A, Aubin M, Roach M, Shinohara K, Pouliot J. Positional Stability of Electromagnetic Transponders Used for Prostate Localization and Continuous, Real-Time Tracking. Int J Radiat Oncol Biol Phys 2007; 68:1199-206. [PMID: 17513060 DOI: 10.1016/j.ijrobp.2007.03.030] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2006] [Revised: 03/08/2007] [Accepted: 03/12/2007] [Indexed: 10/23/2022]
Abstract
PURPOSE To determine the relative positional stability of implanted glass-encapsulated circuits (transponders) used in continuous electromagnetic localization and tracking of target volumes during radiation therapy. Ideally, the distances between transponders remains constant over the course of treatment. In this work, we evaluate the accuracy of these conditions. METHODS AND MATERIALS Three transponders were implanted in each of 20 patients. Images (CT scan or X-ray pair) were acquired at 13 time points. These images occurred from the day of implant (2 weeks before simulation) to 4 weeks posttreatment. The distance between transponders was determined from each dataset. The average and standard deviation of each distance were determined, and changes were evaluated over several time periods, including pretreatment and during therapy. RESULTS Of 60 transponders implanted, 58 showed no significant migration from their intended positions. Of the two transponders that did migrate, one appears to have been implanted in the venous plexus, and the other in the urethra, with no clinical consequences to the patients. An analysis that included the planning CT scan and all subsequent distance measurements showed that the standard deviation of intertransponder distances was < or =1.2 mm for up to 1 month after the completion of therapy. CONCLUSIONS Implanted transponders demonstrate the same long-term stability characteristics as implanted gold markers, within statistical uncertainties. As with gold markers, and using the same implant procedure, basic guidelines for the placement of transponders within the prostate help ensure minimal migration.
Collapse
Affiliation(s)
- Dale W Litzenberg
- Department of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Drever L, Hilts M. Daily quality assurance phantom for ultrasound image guided radiation therapy. J Appl Clin Med Phys 2007; 8:126-136. [PMID: 17712304 PMCID: PMC5722610 DOI: 10.1120/jacmp.v8i3.2467] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2007] [Revised: 03/20/2007] [Accepted: 12/31/1969] [Indexed: 12/02/2022] Open
Abstract
A simple phantom was designed, constructed, tested, and clinically implemented for daily quality assurance (QA) of an ultrasound‐image‐guided radiation therapy (US‐IGRT) system, the Restitu Ultrasound system (Resonant Medical, Montreal, QC). The phantom consists of a high signal echogenic background gel surrounding a low signal hypoechoic egg‐shaped target. Daily QA checks involve ultrasound imaging of the phantom and segmenting of the embedded target using the automated tools available on the US‐IGRT system. This process serves to confirm system hardware and software functions and, in particular, accurate determination of the target position. Experiments were conducted to test the stability of the phantom at room temperature, its tissue‐mimicking properties, the reproducibility of target position measurements, and the usefulness of the phantom as a daily QA device. The phantom proved stable at room temperature, exhibited no evidence of bacterial or fungal invasion in 9 months, and showed limited desiccation (resulting in a monthly reduction in ultrasound‐measured volume of approximately 0.2 cm3). Furthermore, the phantom was shown to be nearly tissue‐mimicking, with speed of sound in the phantom estimated to be 0.8% higher than that assumed by the scanner calibration. The phantom performs well in a clinical setting, owing to its light weight and ease of operation. It provides reproducible measures of target position even with multiple users. At our center, the phantom is being used for daily QA of the US‐IGRT system with clinically acceptable tolerances of ±1 cm3 on target volume and ±2 mm on target position. For routine daily QA, this phantom is a good alternative to the manufacturer‐supplied calibration phantom, and we recommended that that larger phantom be reserved for less frequent, more detailed QA checks and system calibration. PACS numbers: 87.66.Xa, 87.63.Df
Collapse
Affiliation(s)
- Laura Drever
- Department of Medical PhysicsBC Cancer AgencyVictoriaBritish ColumbiaCanada
| | - Michelle Hilts
- Department of Medical PhysicsBC Cancer AgencyVictoriaBritish ColumbiaCanada
| |
Collapse
|
34
|
Abstract
We have investigated the influence of the linear accelerator (LINAC) monitor chamber calibration on the dosimetry of Siemens Virtual Wedge (VW.) The doses delivered in the three phases of wedge delivery (initial gap, sweep portion, and open field) utilize the ionization current generated in two dose monitoring ion chambers (MONITOR 1 and MONITOR 2) in the LINAC to control the wedge delivery. We intentionally offset the calibration of each of these chambers by +/- 3% and observed up to a 13% change in the dose along the wedge profile for a 6 MV beam at a field size of 20 x 20 cm2. If the calibration of one of the two dose monitoring chambers changed independently then the relative dose at points along the wedge profile were affected. Furthermore, the percentage change in dose varied across the wedge profile thereby affecting the wedge angle as well as the central axis wedge factor. We also present equations for calculating the change in dose at a position along the wedge profile as a function of monitor chamber calibration. A comparison with measurement showed that our theoretical predictions were accurate to within +/- 1.7%. The equations have proven useful tools in evaluating periodic drifts in VW dosimetry.
Collapse
Affiliation(s)
- K E Malkoske
- Department of Medical Physics, CancerCare Manitoba, 675 McDermot Ave., Winnipeg, Manitoba, Canada R3E 0V9.
| | | |
Collapse
|
35
|
Craft D, Süss P, Bortfeld T. The Tradeoff Between Treatment Plan Quality and Required Number of Monitor Units in Intensity-modulated Radiotherapy. Int J Radiat Oncol Biol Phys 2007; 67:1596-605. [PMID: 17394954 DOI: 10.1016/j.ijrobp.2006.11.034] [Citation(s) in RCA: 71] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2006] [Revised: 11/13/2006] [Accepted: 11/16/2006] [Indexed: 11/22/2022]
Abstract
PURPOSE To provide a mathematical approach for quantifying the tradeoff between intensity-modulated radiotherapy (IMRT) complexity and plan quality. METHODS AND MATERIALS We solve a multi-objective program that includes IMRT complexity, measured as the number of monitor units (MU) needed to deliver the plan using a multileaf collimator, as an objective. Clinical feasibility of plans is ensured by the use of hard constraints in the formulation. Optimization output is a Pareto surface of treatment plans, which allows the tradeoffs between IMRT complexity, tumor coverage, and tissue sparing to be observed. Paraspinal and lung cases are presented. RESULTS Although the amount of possible MU reduction is highly dependent on the difficulty of the underlying treatment plan (difficult plans requiring a high degree of intensity modulation are more sensitive to MU reduction), in some cases the number of MU can be reduced more than twofold with a <1% increase in the objective function. CONCLUSIONS The largely increased number of MU and irradiation time in IMRT is sometimes unnecessary. Tools like the one presented should be considered for integration into daily clinical practice to avoid this problem.
Collapse
Affiliation(s)
- David Craft
- Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
| | | | | |
Collapse
|
36
|
Buonamici FB, Compagnucci A, Marrazzo L, Russo S, Bucciolini M. An intercomparison between film dosimetry and diode matrix for IMRT quality assurance. Med Phys 2007; 34:1372-9. [PMID: 17500468 DOI: 10.1118/1.2713426] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The evaluation of the agreement between measured and calculated dose plays an essential role in the quality assurance (QA) procedures for intensity modulated radiation therapy (IMRT). Film dosimetry has been widely adopted for this purpose due to excellent film characteristics in terms of spatial resolution; unfortunately, it is a time-consuming procedure and requires great care if film has to be used as an absolute dosimeter. If this is not the case, then an independent ionimetric measurement is mandatory to assess the absolute dose agreement. Arrays of detectors are now replacing films for routine IMRT QA, since they permit very simple verification procedures. They show excellent characteristics in terms of linearity, repeatability, and independence of the response from the dose rate, but at the same time present a poor spatial resolution, due to the limited number of detectors available. In our institution, a diode matrix (MapCHECK, provided by Sun Nuclear) is adopted for routine QA. The aim of this work is to compare the performances of absolute film dosimetry with this matrix in QA procedures and to investigate the origin of possible discrepancies between the two methods. The results we present show a very good agreement between the two detectors when used to assess the mean dose deviation between calculated and measured doses (in both cases 0.2%). If the y matrix method is adopted, MapCHECK response shows a slightly better agreement with computed dose distribution than film dosimetry (mean percentage of points satisfying the constraint y < or = 1: 96% versus 94%). This difference is shown not to depend on the different field sampling, but on the detectors' capabilities. Moreover, we show that the diode matrix is able to identify eventual delivery errors as well as film. Our conclusion is that the diode matrix may effectively replace both film dosimetry and ionimetric measurements in routine IMRT QA.
Collapse
Affiliation(s)
- F Banci Buonamici
- SOD Fisica Medica, Azienda Ospedaliero-Universitaria Careggi-viale Morgagni 85, I-50134 Firenze, Italy.
| | | | | | | | | |
Collapse
|
37
|
Both S, Alecu IM, Stan AR, Alecu M, Ciura A, Hansen JM, Alecu R. A study to establish reasonable action limits for patient-specific quality assurance in intensity-modulated radiation therapy. J Appl Clin Med Phys 2007; 8:1-8. [PMID: 17592459 PMCID: PMC5722409 DOI: 10.1120/jacmp.v8i2.2374] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2006] [Revised: 01/12/2007] [Accepted: 12/31/1969] [Indexed: 12/05/2022] Open
Abstract
An effective patient quality assurance (QA) program for intensity‐modulated radiation therapy (IMRT) requires accurate and realistic plan acceptance criteria—that is, action limits. Based on dose measurements performed with a commercially available two‐dimensional (2D) diode array, we analyzed 747 fluence maps resulting from a routine patient QA program for IMRT plans. The fluence maps were calculated by three different commercially available (ADAC, CMS, Eclipse) treatment planning systems (TPSs) and were delivered using 6‐MV X‐ray beams produced by linear accelerators. To establish reasonably achievable and clinically acceptable limits for the dose deviations, the agreement between the measured and calculated fluence maps was evaluated in terms of percent dose error (PDE) for a few points and percent of passing points (PPP) for the isodose distribution. The analysis was conducted for each TPS used in the study (365 ADAC, 162 CMS, 220 Eclipse), for multiple treatment sites (prostate, pelvis, head and neck, spine, rectum, anus, lung, brain), at the normalization point for 3% percentage difference (%Diff) and 3‐mm distance to agreement (DTA) criteria. We investigated the treatment‐site dependency of PPP and PDE. The results show that, at 3% and 3‐mm criteria, a 95% PPP and 3% PDE can be achieved for prostate treatments and a 90% PPP and 5% PDE are attainable for any treatment site. PACS Numbers: 87.53Dq, 87.53Tf, 87.53Xd, 87.56Fc
Collapse
Affiliation(s)
- Stefan Both
- Department of Radiation Oncology, Medical Physics Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
| | | | | | | | | | | | | |
Collapse
|
38
|
Abstract
✓In this report the authors review the use of radiotherapy in the treatment of central nervous system (CNS) metastasis. They comment on different treatment methods for both intracranial and extracranial CNS metastasis and discuss some of the evidence supporting the use of radiotherapy in these settings. Recent advancements in radiation oncology technology are briefly reviewed with a focus on the advantages and disadvantages of helical TomoTherapy–based treatment strategies.
A review of pertinent current literature was performed. TomoTherapy research currently underway at the University of Virginia Health System is discussed and a representative case is presented.
Radiotherapy for CNS metastasis is an effective treatment that provides palliation of symptoms and confers a survival advantage on selected patients. Advances in radiotherapy techniques continue to improve the therapeutic ratio for patients with CNS metastases.
Helical TomoTherapy offers distinct advantages for patients with CNS metastatic disease by sparing normal tissue when intracranial or extracranial disease is targeted.
Collapse
Affiliation(s)
- Joseph M Baisden
- Department of Radiation Oncology, University of Virginia Health System, Charlottesville, Virginia 22908, USA
| | | | | | | | | |
Collapse
|
39
|
Zhou LH, Tang MT, Wang ZY, Chen CM, Lü QW, Jin HY. [Genetic algorithm-based dose optimization in intensity modulated radiation therapy]. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27:46-8. [PMID: 17259143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
As a powerful global optimization approach, genetic algorithms (GA) can solve a variety of optimization problems in which the objective function is discontinuous, non-differentiable, or highly non-linear, to produce high convergence speed and vast search space. In this thesis, GA is used to optimize the beam weights of intensity modulated radiation therapy (IMRT) inverse planning, and 2D and 3D isodose contour as well as dose volume histogram (DVH) are used to evaluate the treatment plan. Also presented in this thesis are the results of calculation with discussions.
Collapse
Affiliation(s)
- Ling-Hong Zhou
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.
| | | | | | | | | | | |
Collapse
|
40
|
Senan S, Piet A, Lagerwaard F. Involved-node radiotherapy to the mediastinum. Radiother Oncol 2007; 82:108-9; author reply 109-10. [PMID: 17125861 DOI: 10.1016/j.radonc.2006.10.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2006] [Accepted: 10/03/2006] [Indexed: 11/18/2022]
|
41
|
Kanagaki B, Read PW, Molloy JA, Larner JM, Sheng K. A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion. Phys Med Biol 2006; 52:243-55. [PMID: 17183139 DOI: 10.1088/0031-9155/52/1/016] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Helical tomotherapy (HT) can potentially be used for lung cancer treatment including stereotactic radiosurgery because of its advanced image guidance and its ability to deliver highly conformal dose distributions. However, previous theoretical and simulation studies reported that the effect of respiratory motion on statically planned tomotherapy treatments may cause substantial differences between the calculated and actual delivered radiation isodose distribution, particularly when the treatment is hypofractionated. In order to determine the dosimetric effects of motion upon actual HT treatment delivery, phantom film dosimetry measurements were performed under static and moving conditions using a clinical HT treatment unit. The motion phantom system was constructed using a programmable motor, a base, a moving platform and a life size lung heterogeneity phantom with wood inserts representing lung tissue with a 3.0 cm diameter spherical tumour density equivalent insert. In order to determine the effects of different motion and tomotherapy delivery parameters, treatment plans were created using jaw sizes of 1.04 cm and 2.47 cm, with incremental gantry rotation periods between the minimum allowed (10 s) and the maximum allowed (60 s). The couch speed varied from 0.009 cm s(-1) to 0.049 cm s(-1), and delivered to a phantom under static and dynamic conditions with peak-to-peak motion amplitudes of 1.2 cm and 2 cm and periods of 3 and 5 s to simulate human respiratory motion of lung tumours. A cylindrical clinical target volume (CTV) was contoured to tightly enclose the tumour insert. 2.0 Gy was prescribed to 95% of the CTV. Two-dimensional dose was measured by a Kodak EDR2 film. Dynamic phantom doses were then quantitatively compared to static phantom doses in terms of axial dose profiles, cumulative dose volume histograms (DVH), percentage of CTV receiving the prescription dose and the minimum dose received by 95% of the CTV. The larger motion amplitude resulted in more under-dosing at the ends of the CTV in the axis of motion, and this effect was greater for the smaller jaw size plans. Due to the size of the penumbra, the 2.47 cm jaw plans provide adequate coverage for smaller amplitudes of motion, +/-0.6 cm in our experiment, without adding any additional margin in the axis of motion to the treatment volume. The periodic heterogeneous patterns described by previous studies were not observed from the single fraction of the phantom measurement. Besides the jaw sizes, CTV dose coverage is not significantly dependent on machine and phantom motion periods. The lack of adverse synchronization patterns from both results validate that HT is a safe technique for treating moving target and hypofractionation.
Collapse
Affiliation(s)
- Brian Kanagaki
- Department of Engineering Physics, University of Virginia, Charlottesville, VA 22908, USA.
| | | | | | | | | |
Collapse
|
42
|
Daisne JF, Grégoire V. [Multimodalities imaging for target volume definition in radiotherapy]. Bull Cancer 2006; 93:1175-82. [PMID: 17182373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Modern radiotherapy delivery nowadays relies on tridimensional, conformal techniques. The aim is to better target the tumor while decreasing the dose administered to surrounding normal tissues. Gold standard imaging modality remains computed-tomography (CT) scanner. However, the intrinsic lack of contrast between soft tissues leads to high variabilities in target definition. The risks are : a geographical miss with tumor underirradiation on the one hand, and a tumor overestimation with undue normal tissues irradiation on the other hand. Alternative imaging modalities like magnetic resonance imaging and functional positron emission tomography could theoretically overcome the lack of soft tissues contrast of CT. However, the fusion of the different imaging modalities images requires the use of sophisticated computer algorithms. We will briefly review them. We will then review the different clinical results reported with multi-modalities imaging for tumors of the head, neck, lung, esophagus, cervix and lymphomas. Finally, we will briefly give practical recommendations for multi-modality imaging in radiotherapy treatment planning process.
Collapse
Affiliation(s)
- Jean-François Daisne
- Service de radiothérapie oncologique et Unité d'imagerie moléculaire et de radiothérapie expérimentale (IMRE), Cliniques universitaires Saint-Luc, avenue Hippocrate, 10, B-1200 Bruxelles, Belgique
| | | |
Collapse
|
43
|
Yoo S, Kim GY, Hammoud R, Elder E, Pawlicki T, Guan H, Fox T, Luxton G, Yin FF, Munro P. A quality assurance program for the on-board imager®. Med Phys 2006; 33:4431-47. [PMID: 17153422 DOI: 10.1118/1.2362872] [Citation(s) in RCA: 124] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
To develop a quality assurance (QA) program for the On-Board Imager (OBI) system and to summarize the results of these QA tests over extended periods from multiple institutions. Both the radiographic and cone-beam computed tomography (CBCT) mode of operation have been evaluated. The QA programs from four institutions have been combined to generate a series of tests for evaluating the performance of the On-Board Imager. The combined QA program consists of three parts: (1) safety and functionality, (2) geometry, and (3) image quality. Safety and functionality tests evaluate the functionality of safety features and the clinical operation of the entire system during the tube warm-up. Geometry QA verifies the geometric accuracy and stability of the OBI/CBCT hardware/software. Image quality QA monitors spatial resolution and contrast sensitivity of the radiographic images. Image quality QA for CBCT includes tests for Hounsfield Unit (HU) linearity, HU uniformity, spatial linearity, and scan slice geometry, in addition. All safety and functionality tests passed on a daily basis. The average accuracy of the OBI isocenter was better than 1.5 mm with a range of variation of less than 1 mm over 8 months. The average accuracy of arm positions in the mechanical geometry QA was better than 1 mm, with a range of variation of less than 1 mm over 8 months. Measurements of other geometry QA tests showed stable results within tolerance throughout the test periods. Radiographic contrast sensitivity ranged between 2.2% and 3.2% and spatial resolution ranged between 1.25 and 1.6 lp/mm. Over four months the CBCT images showed stable spatial linearity, scan slice geometry, contrast resolution (1%; <7 mm disk) and spatial resolution (>6 lp/cm). The HU linearity was within +/-40 HU for all measurements. By combining test methods from multiple institutions, we have developed a comprehensive, yet practical, set of QA tests for the OBI system. Use of the tests over extended periods show that the OBI system has reliable mechanical accuracy and stable image quality. Nevertheless, the tests have been useful in detecting performance deficits in the OBI system that needed recalibration. It is important that all tests are performed on a regular basis.
Collapse
Affiliation(s)
- Sua Yoo
- Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Stasi M, Munoz F, Fiorino C, Pasquino M, Baiotto B, Marini P, Malinverni G, Valdagni R, Gabriele P. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer. Radiother Oncol 2006; 80:363-70. [PMID: 16959344 DOI: 10.1016/j.radonc.2006.08.007] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2005] [Revised: 08/04/2006] [Accepted: 08/11/2006] [Indexed: 10/24/2022]
Abstract
PURPOSE To investigate the impact of rectum motion on dose - volume histograms of the rectum including filling and of the wall (DVH and DWH, respectively), during 3D-conformal radiotherapy (3DCRT) for localized prostate cancer. MATERIALS AND METHODS Ten patients received a planning CT scan (CT(0)) and 11-14 CT during 3DCRT for prostate cancer (total CT scans=126). CT images were 3D matched using bony anatomy. A single observer drew the external contours of rectum and rectum wall and the CTV (prostate + seminal vesicles) on CT(0). Patients were asked to empty their rectum before every CT, as generally performed at the Institute for Cancer Research and Treatment (IRCC) before treatment delivery. Bladder was kept full by drinking 500 cm(3) of water 60 min before the scan, according to our protocol. A 4-field box 3DCRT technique was planned and dose statistics/dose - volume histograms of the rectum were calculated for each contour referred to CT(0),CT(1),...,CT(n) for each patient. Average DVHs during treatment were calculated along with their standard deviation (SD(rand)) and compared to the planned DVH. The analyses on the patient population included the assessment of systematic deviation (average difference and SD, named SD(sys)) as well as the average SD(rand) value expressing the random component of organ motion. Rectum shifts were also assessed by anterior and lateral BEV projections. RESULTS As to the rectum, 8/10 patients showed a "better" average DVH than DVH on CT(0). Wilcoxon test showed a statistically significant reduction when correlating the difference Delta between the average DVH during therapy and planning DVH at CT(0): for instance V(70)Delta = -3.6% and p = 0.022, V(50)Delta = -5.5% and p = 0.022, D(med)Delta = -3.2 Gy and p = 0.007. Average values of DVH systematic difference (average difference between planning scan and treatment), standard deviations (SD(sys)) and average standard deviations of the random fluctuation (SD(random)) were -4.0%, 4.7% and 6.6%, respectively. Whilst the fluctuation results were slightly smaller for DWH. Volume analysis showed a slight systematic variation of the rectal volume between planning and treatment BEV. The average rectal volume during therapy was larger than at the planning CT in 8/10 patients. The systematic shifts of the rectal wall between the planning phase and the treatment were rather small, both below and above the flexure. The larger random fluctuation of the rectum shape was found to be in the cranial half (1 SD=4.4 mm). CONCLUSIONS The practice of carefully emptying the rectum during simulation and therapy for prostate cancer, which is a safe and simple procedure, reduces the impact of organ motion on dose - volume parameters of the rectum.
Collapse
Affiliation(s)
- Michele Stasi
- S.C. Fisica Sanitaria, Institute for Cancer Research and Treatment (IRCC), Candiolo (Torino), Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Smyslov AI, Konchili IN, Lebedev LA, Khmelevskiĭ EB. [Comparative analysis of dose distribution in photon and proton therapy of prostate cancer]. Med Tekh 2006:16-20. [PMID: 17133938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Comparative analysis of the dose distribution in photon and proton therapy of prostate cancer is performed. The degree of exposure of healthy organs to radiation is assessed for each of the two treatment techniques using the time-dose-fractionation parameter.
Collapse
|
46
|
Abstract
In intensity modulated radiation treatments (IMRT), the position of the field edges and the modulation within the beam are often achieved with a multileaf collimator (MLC). During the MLC calibration process, due to the finite accuracy of leaf position measurements, a systematic error may be introduced to leaf positions. Thereafter leaf positions of the MLC depend on the systematic error introduced on each leaf during MLC calibration and on the accuracy of the leaf position control system (random errors). This study presents and evaluates two methods to predict the systematic errors on the leaf positions introduced during the MLC calibration. The two presented methods are based on a series of electronic portal imaging device (EPID) measurements. A comparison with film measurements showed that the EPID could be used to measure leaf positions without introducing any bias. The first method, referred to as the "central leaf method," is based on the method currently used at this center for MLC leaf calibration. It mimics the manner in which leaf calibration parameters are specified in the MLC control system and consequently is also used by other centers. The second method, a new method proposed by the authors and referred to as the "individual leaf method," involves the measurement of two positions for each leaf (-5 and +15 cm) and the interpolation and extrapolation from these two points to any other given position. The central leaf method and the individual leaf method predicted leaf positions at prescribed positions of -11, 0, 5, and 10 cm within 2.3 and 1.0 mm, respectively, with a standard deviation (SD) of 0.3 and 0.2 mm, respectively. The individual leaf method provided a better prediction of the leaf positions than the central leaf method. Reproducibility tests for leaf positions of -5 and +15 cm were performed. The reproducibility was within 0.4 mm on the same day and 0.4 mm six weeks later (1 SD). Measurements at gantry angles of 0 degrees, 90 degrees, and 270 degrees for leaf positions of -5 and +15 cm showed no significant effect of gravity. The individual leaf method could be used in various applications to improve the accuracy of radiotherapy treatment from planning to delivery. Three cases are discussed: IMRT beam verification, MLC calibration and dose calculation.
Collapse
Affiliation(s)
- Laure Parent
- Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT United Kingdom.
| | | | | | | | | |
Collapse
|
47
|
Abstract
The purpose of this study was to investigate the impact on localization of utilizing contrast-enhanced CT scans and the formal input of a radiologist in the planning process. 25 head and neck/brain patients had pre- and post-contrast CT scans in the treatment position. Radiotherapy treatment was planned on the unenhanced CT images as per standard practice. Retrospectively, their scans (unenhanced and enhanced) were re-contoured by two oncologists and a radiologist. These new contours were compared with the original unenhanced treatment contours and differences in contour volume, geographical isocentre position and tolerance coverage of the associated planning target volumes (PTVs) were evaluated using the original plans. The use of contrast enhanced CT data during localization by the oncologist shows little change in gross tumour volumes (GTVs) or PTVs, geographical position or tolerance coverage for the targets in the brain studied here. Larger changes in mean volume are seen for the head and neck cases alone. Changes are greater and statistically significant (p < 0.05, Wilcoxon signed rank test) for localization by the radiologist. Furthermore, when comparing the original PTV marked by the oncologist with a new PTV re-contoured by the oncologist, but based on a GTV marked-up by the radiologist, again statistically significant (p < 0.01) changes in percentage volume are noted. Intraoperator precision is good, percentage volume differences being of the order 3-6%. PTVs also show improved standard deviations compared with GTVs. Geographic shifts are generally within our departmental tolerance levels for daily patient setup. Comparing precision of unenhanced data with enhanced, mean percentage volume changes are smaller, but not statistically significant. The use of enhanced scan data for localization has little effect on size, geographical position or tolerance coverage of PTVs marked up by the oncologists in this study. However, more important is the input from a radiologist. Statistically significant differences due to mark-up on enhanced scans by the radiologist are shown. Furthermore, significant differences are also seen between PTVs based on oncologist-generated GTVs, and those based on radiologist-generated GTVs.
Collapse
Affiliation(s)
- M McJury
- Department of Radiotherapy Physics, Weston Park Hospital, Whitham Road, Sheffield, UK
| | | | | | | | | |
Collapse
|
48
|
Kanai T, Kanematsu N, Minohara S, Komori M, Torikoshi M, Asakura H, Ikeda N, Uno T, Takei Y. Commissioning of a conformal irradiation system for heavy-ion radiotherapy using a layer-stacking method. Med Phys 2006; 33:2989-97. [PMID: 16964877 DOI: 10.1118/1.2219771] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The commissioning of conformal radiotherapy system using heavy-ion beams at the Heavy Ion Medical Accelerator in Chiba (HIMAC) is described in detail. The system at HIMAC was upgraded for a clinical trial using a new technique: large spot uniform scanning with conformal layer stacking. The system was developed to localize the irradiation dose to the target volume more effectively than with the old system. With the present passive irradiation method using a ridge filter, a scatterer, a pair of wobbler magnets, and a multileaf collimator, the width of the spread-out Bragg peak (SOBP) in the radiation field could not be changed. With dynamic control of the beam-modifying devices during irradiation, a more conformal radiotherapy could be achieved. In order to safely perform treatments with this conformal therapy, the moving devices should be watched during irradiation and the synchronousness among the devices should be verified. This system, which has to be safe for patient irradiations, was constructed and tested for safety and for the quality of the dose localization realized. Through these commissioning tests, we were successfully able to prepare the conformal technique using layer stacking for patients. Subsequent to commissioning the technique has been applied to patients in clinical trials.
Collapse
Affiliation(s)
- Tatsuaki Kanai
- Department of Medical Physics, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Nicolini G, Fogliata A, Vanetti E, Clivio A, Cozzi L. GLAaS: An absolute dose calibration algorithm for an amorphous silicon portal imager. Applications to IMRT verifications. Med Phys 2006; 33:2839-51. [PMID: 16964860 DOI: 10.1118/1.2218314] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
A new calibration algorithm (GLAaS) to derive absolute dose maps from images acquired with the Varian PV-aS500 electronic portal imager (based on amorphous silicon detectors) has been developed incorporating the dependence of detector response on primary and transmitted radiation and on field size. Detector calibration and algorithm validation were performed at different depths (10.0, 3.8, 1.5, and 0.8 cm) in solid water to investigate various application possibilities. Calibration data were obtained against ion chamber measurements. Validation experiments were performed on intensity-modulated fields and comparison was carried out against calculated dose maps as well as against film measurements. Split fields were acquired independently and PV-aS500 images were summed offline with the new algorithm allowing complex fields to be verified in conditions most closely resembling clinical conditions. Excellent results were obtained for the 3.8, 1.5, and 0.8 depths on a set of 34 modulated fields including both split and nonsplit fields. Applying the gamma index analysis (with distance to agreement and dose thresholds set to 3 mm and 4%, respectively), only 2.3% of the field area showed gamma > 1 at 1.5 cm depth (8.1%, 3.1%, 2.7% at 10.0, 3.8, and 0.8 and 2.5% with films at 10 cm depth). Tests were also performed to verify GLAaS at gantry angles different from 0 degrees. No statistical differences were obtained for the comparison between split and nonsplit fields and between different gantry angles. Highly significant statistical differences were obtained when comparing independent samples of 240 fields verified either with GLAaS or with film. Fields verified with GLAaS presented a mean area with gamma > 1 of 2.1 +/-1.3% while for film this value was 3.9 +/- 3.4% (p<0.001). Absolute dosimetry proved to be reliable with the PV-aS500 detector with the GLAaS algorithm. The minimal settings at depths of 1.5 or 3.8 cm would allow the use of the detector at any gantry angle without the need for any special fixation tool.
Collapse
Affiliation(s)
- Giorgia Nicolini
- Medical Physics Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
| | | | | | | | | |
Collapse
|
50
|
de Dios NR, Arnalot PF, Latiesas XS, Lopez MA. Target contouring protocol for 3D conformal radiotherapy in lung cancer. Int J Radiat Oncol Biol Phys 2006; 65:1275-6; author reply 1276-7. [PMID: 16798423 DOI: 10.1016/j.ijrobp.2006.03.037] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2006] [Accepted: 03/27/2006] [Indexed: 11/27/2022]
|